BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671-722. [PMID: 31863477 DOI: 10.1002/hep.31065] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 52.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, Wang FS, Wei L, Wang Q, Sun Y, Hong Y, Rao H, Efe C, Lau G, Payawal D, Gani R, Lindor K, Jafri W, Omata M, Sarin SK. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int 2021;15:223-57. [PMID: 33942203 DOI: 10.1007/s12072-021-10170-1] [Reference Citation Analysis]
2 L Volk M, Reau N. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: A Patient-Friendly Summary of the 2019 AASLD Guidelines. Clin Liver Dis (Hoboken) 2021;17:85-9. [PMID: 33680442 DOI: 10.1002/cld.1080] [Reference Citation Analysis]
3 Zhang HC, Wang LS, Miller E. Hepatobiliary and Pancreatic Adverse Events. Adv Exp Med Biol 2021;1342:339-55. [PMID: 34972973 DOI: 10.1007/978-3-030-79308-1_13] [Reference Citation Analysis]
4 Saerens M, Kruse V, Lybaert W. Strategies to overcome relapse of immunotherapy-related hepatitis: dose reduction is not the key. Acta Clin Belg 2021;:1-6. [PMID: 33754957 DOI: 10.1080/17843286.2021.1903662] [Reference Citation Analysis]
5 Marrone G, Galati F, Biolato M, Oddy C, De Carolis S, Zoli A, Grieco A. Acute liver failure in Still's disease relapse during pregnancy: case report and discussion of a possible trigger role of DILI. BMC Gastroenterol 2021;21:317. [PMID: 34362307 DOI: 10.1186/s12876-021-01878-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Xue M, Shen Y, Fan X, Shen M, Yang L. Autoimmune Hepatitis with Elevated Serum IgG4 Levels Have a High Prevalence of Cirrhosis at Diagnosis.Can J Gastroenterol Hepatol. 2021;2021:6692511. [PMID: 33489994 DOI: 10.1155/2021/6692511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhang H, Liu M, Zhong W, Zheng Y, Li Y, Guo L, Zhang Y, Ran Y, Zhao J, Zhou L, Wang B. Leaky Gut Driven by Dysbiosis Augments Activation and Accumulation of Liver Macrophages via RIP3 Signaling Pathway in Autoimmune Hepatitis. Front Immunol 2021;12:624360. [PMID: 33841405 DOI: 10.3389/fimmu.2021.624360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Sripongpun P, Pongpaibul A, Charatcharoenwitthaya P. Value and risk of percutaneous liver biopsy in patients with cirrhosis and clinical suspicion of autoimmune hepatitis. BMJ Open Gastroenterol 2021;8:e000701. [PMID: 34362759 DOI: 10.1136/bmjgast-2021-000701] [Reference Citation Analysis]
9 Talbot S, MacLaren V, Lafferty H. Sclerosing cholangitis in a patient treated with nivolumab. BMJ Case Rep 2021;14:e241700. [PMID: 34049893 DOI: 10.1136/bcr-2021-241700] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. A reasoned approach to the treatment of autoimmune hepatitis. Dig Liver Dis 2021:S1590-8658(21)00307-8. [PMID: 34162505 DOI: 10.1016/j.dld.2021.05.033] [Reference Citation Analysis]
11 Jenkins A, Austin A, Hughes K, Sadowski B, Torres D. Infliximab-induced autoimmune hepatitis. BMJ Case Rep 2021;14:e239944. [PMID: 34031069 DOI: 10.1136/bcr-2020-239944] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Chalasani S, Mathur K, Shammas N, Orman E, Vuppalanchi R, Lammert C. Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis. Medicine (Baltimore) 2020;99:e22805. [PMID: 33080756 DOI: 10.1097/MD.0000000000022805] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhang C, Qiu Z, Zhang L, Pang Q, Yang Z, Qin JK, Liang H, Zhao S. Design and synthesis of a ratiometric photoacoustic imaging probe activated by selenol for visual monitoring of pathological progression of autoimmune hepatitis. Chem Sci 2021;12:4883-8. [PMID: 34163738 DOI: 10.1039/d0sc06573k] [Reference Citation Analysis]
14 Matarazzo L, Nastasio S, Sciveres M, Maggiore G. Pregnancy outcome in women with childhood onset autoimmune hepatitis and autoimmune sclerosing cholangitis on long-term immunosuppressive treatment. Eur J Obstet Gynecol Reprod Biol 2021;268:7-11. [PMID: 34788721 DOI: 10.1016/j.ejogrb.2021.10.030] [Reference Citation Analysis]
15 Liu C, Wang YL, Yang YY, Zhang NP, Niu C, Shen XZ, Wu J. Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases. FASEB J 2021;35:e21871. [PMID: 34473374 DOI: 10.1096/fj.202100939R] [Reference Citation Analysis]
16 Chen ZY, Zhu YH, Zhou LY, Shi WQ, Qin Z, Wu B, Yan Y, Pei YW, Chao NN, Zhang R, Wang MY, Su ZH, Lu XJ, He ZY, Xu T. Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study. Front Pharmacol 2021;12:672769. [PMID: 34084143 DOI: 10.3389/fphar.2021.672769] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhou YJ, Zheng KI, Ma HL, Li G, Pan XY, Zhu PW, Targher G, Byrne CD, Wang XD, Chen YP, Li XB, Zheng MH. Association between positivity of serum autoantibodies and liver disease severity in patients with biopsy-proven NAFLD. Nutr Metab Cardiovasc Dis 2021;31:552-60. [PMID: 33250371 DOI: 10.1016/j.numecd.2020.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li SS, Niu M, Jing J, Huang Y, Zhang ZT, Chen SS, Shi GZ, He X, Zhang HZ, Xiao XH, Zou ZS, Yu YC, Wang JB. Metabolomic Signatures of Autoimmune Hepatitis in the Development of Cirrhosis. Front Med (Lausanne) 2021;8:644376. [PMID: 33777984 DOI: 10.3389/fmed.2021.644376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ronca V, Bozward AG, Oo YH. Use of immunosuppression in non-transplant hepatology. Best Pract Res Clin Gastroenterol 2021;54-55:101760. [PMID: 34874849 DOI: 10.1016/j.bpg.2021.101760] [Reference Citation Analysis]
20 van den Brand FF, Snijders RJALM, de Boer YS, Verwer BJ, van Nieuwkerk CMJ, Bloemena E, Kuiken SD, Drenth JPH, Bouma G. Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study. Eur J Intern Med 2021;90:30-6. [PMID: 33865679 DOI: 10.1016/j.ejim.2021.03.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kemme S, Mack CL. Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis. Pediatr Clin North Am 2021;68:1293-307. [PMID: 34736590 DOI: 10.1016/j.pcl.2021.07.006] [Reference Citation Analysis]
22 Laschtowitz A, Zachou K, Lygoura V, Pape S, Derben F, Jaeckel E, Oller-Moreno S, Weidemann S, Krech T, Piecha F, Schön G, Liebhoff AM, Al Tarrah M, Heneghan M, Drenth JPH, Dalekos G, Taubert R, Lohse AW, Schramm C. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis. JHEP Rep 2021;3:100321. [PMID: 34381983 DOI: 10.1016/j.jhepr.2021.100321] [Reference Citation Analysis]
23 Tanaka A, Notohara K. Immunoglobulin G4 (IgG4)-related autoimmune hepatitis and IgG4-hepatopathy: A histopathological and clinical perspective. Hepatol Res 2021;51:850-9. [PMID: 34165225 DOI: 10.1111/hepr.13683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Czaja AJ. Immune Inhibitory Properties and Therapeutic Prospects of Transforming Growth Factor-Beta and Interleukin 10 in Autoimmune Hepatitis. Dig Dis Sci 2021. [PMID: 33835375 DOI: 10.1007/s10620-021-06968-6] [Reference Citation Analysis]
25 Madhu D, Sharma S, Agarwal A, Saraya A. Special Considerations in the Management of Autoimmune Hepatitis in COVID-19 Hotspots: A Review. J Clin Transl Hepatol 2021;9:568-75. [PMID: 34447687 DOI: 10.14218/JCTH.2021.00001] [Reference Citation Analysis]
26 Kerkar N, Mayo MJ. Autoimmune Hepatitis: Highlights for Liver Transplant Providers From the American Association for the Study of Liver Diseases 2019 Guidelines. Liver Transpl 2020;26:973-6. [PMID: 32133751 DOI: 10.1002/lt.25740] [Reference Citation Analysis]
27 Sirbe C, Simu G, Szabo I, Grama A, Pop TL. Pathogenesis of Autoimmune Hepatitis-Cellular and Molecular Mechanisms. Int J Mol Sci 2021;22:13578. [PMID: 34948375 DOI: 10.3390/ijms222413578] [Reference Citation Analysis]
28 Khedr MA, Salem TA, Boghdadi GM, Elharoun AS, El-Shahaway AA, Atallah HR, Sira MM. Seronegative autoimmune hepatitis in children : A real diagnostic challenge. Wien Klin Wochenschr 2021. [PMID: 34283299 DOI: 10.1007/s00508-021-01907-x] [Reference Citation Analysis]
29 Domerecka W, Kowalska-Kępczyńska A, Michalak A, Homa-Mlak I, Mlak R, Cichoż-Lach H, Małecka-Massalska T. Etiopathogenesis and Diagnostic Strategies in Autoimmune Hepatitis. Diagnostics (Basel) 2021;11:1418. [PMID: 34441353 DOI: 10.3390/diagnostics11081418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Dalekos GN, Azariadis K, Lygoura V, Arvaniti P, Gampeta S, Gatselis NK. Autoimmune hepatitis in patients aged 70 years or older: Disease characteristics, treatment response and outcome. Liver Int 2021;41:1592-9. [PMID: 33896089 DOI: 10.1111/liv.14900] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Efe C, Simşek C, Batıbay E, Calışkan AR, Wahlin S. Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic. Expert Rev Gastroenterol Hepatol 2020;14:1215-9. [PMID: 32909852 DOI: 10.1080/17474124.2020.1822734] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
32 Hadley TA, Palle SK, Venkateswaran S, Abramowsky C, Gillespie S, Hall L, Kolachala VL, Gupta NA. A two decade long study of disease progression of de novo and recurrent autoimmune hepatitis in the pediatric population. Pediatr Transplant 2021;25:e13978. [PMID: 33522659 DOI: 10.1111/petr.13978] [Reference Citation Analysis]
33 Fujiwara K, Nakayama N, Kato N, Yokosuka O, Tsubouchi H, Takikawa H, Mochida S; Intractable Hepato-Biliary Diseases Study Group of Japan. Infectious complications and timing for liver transplantation in autoimmune acute liver failure in Japan: a subanalysis based on nationwide surveys between 2010 and 2015. J Gastroenterol 2020;55:888-98. [PMID: 32556645 DOI: 10.1007/s00535-020-01699-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Granito A, Muratori P, Muratori L. Acute-on-chronic liver failure: A complex clinical entity in patients with autoimmune hepatitis. J Hepatol 2021;75:1503-5. [PMID: 34228991 DOI: 10.1016/j.jhep.2021.06.035] [Reference Citation Analysis]
35 Thomaides-Brears HB, Lepe R, Banerjee R, Duncker C. Multiparametric MR mapping in clinical decision-making for diffuse liver disease. Abdom Radiol (NY). 2020;45:3507-3522. [PMID: 32761254 DOI: 10.1007/s00261-020-02684-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
36 Efe C, Lammert C, Taşçılar K, Dhanasekaran R, Ebik B, Higuera-de la Tijera F, Calışkan AR, Peralta M, Gerussi A, Massoumi H, Catana AM, Purnak T, Rigamonti C, Aldana AJG, Khakoo N, Nazal L, Frager S, Demir N, Irak K, Melekoğlu-Ellik Z, Kacmaz H, Balaban Y, Atay K, Eren F, Alvares-da-Silva MR, Cristoferi L, Urzua Á, Eşkazan T, Magro B, Snijders R, Barutçu S, Lytvyak E, Zazueta GM, Demirezer-Bolat A, Aydın M, Heurgue-Berlot A, De Martin E, Ekin N, Yıldırım S, Yavuz A, Bıyık M, Narro GC, Kıyıcı M, Akyıldız M, Kahramanoğlu-Aksoy E, Vincent M, Carr RM, Günşar F, Reyes EC, Harputluoğlu M, Aloman C, Gatselis NK, Üstündağ Y, Brahm J, Vargas NCE, Güzelbulut F, Garcia SR, Aguirre J, Anders M, Ratusnu N, Hatemi I, Mendizabal M, Floreani A, Fagiuoli S, Silva M, Idilman R, Satapathy SK, Silveira M, Drenth JPH, Dalekos GN, N Assis D, Björnsson E, Boyer JL, Yoshida EM, Invernizzi P, Levy C, Montano-Loza AJ, Schiano TD, Ridruejo E, Wahlin S. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. Liver Int 2021. [PMID: 34846800 DOI: 10.1111/liv.15121] [Reference Citation Analysis]
37 Rahim MN, Miquel R, Heneghan MA. Approach to the patient with acute severe autoimmune hepatitis. JHEP Rep 2020;2:100149. [PMID: 32995712 DOI: 10.1016/j.jhepr.2020.100149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
38 Kemme S, Feldman AG, Mack C. Severe Seronegative Hepatitis-associated Aplastic Anemia: Looking for the Best Treatment. J Pediatr Gastroenterol Nutr 2021;73:e48. [PMID: 34016886 DOI: 10.1097/MPG.0000000000003166] [Reference Citation Analysis]
39 Bittermann T, Mahmud N, Lewis JD, Levy C, Goldberg DS. Validating a novel algorithm to identify patients with autoimmune hepatitis in an administrative database. Pharmacoepidemiol Drug Saf 2021;30:1168-74. [PMID: 33979005 DOI: 10.1002/pds.5291] [Reference Citation Analysis]
40 Rahim MN, Ran S, Shah S, Hughes S, Heneghan MA. Safety and Efficacy of Budesonide During Pregnancy in Women With Autoimmune Hepatitis. Hepatology 2021;73:2601-6. [PMID: 33188708 DOI: 10.1002/hep.31634] [Reference Citation Analysis]
41 Shorbagi AI. Is it time to get rid of the biopsy mandate in adults with suspected autoimmune hepatitis? Lessons from the COVID-19 pandemic. Liver Int 2021. [PMID: 34919326 DOI: 10.1111/liv.15137] [Reference Citation Analysis]
42 Wahlin S, Efe C. Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis. J Hepatol 2021;74:753-5. [PMID: 33309114 DOI: 10.1016/j.jhep.2020.09.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Noguchi F, Chu PS, Taniki N, Yoshida A, Morikawa R, Yamaguchi A, Ikura A, Yamataka K, Hoshi H, Usui S, Ebinuma H, Saito H, Kanai T, Nakamoto N. Long-Term Observation of Cyclosporine as Second-Line Therapy in Adults for Severe Acute Autoimmune Hepatitis. Hepatology 2021;73:2594-7. [PMID: 33068296 DOI: 10.1002/hep.31597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 McEachern E, Carroll AM, Fribourg M, Schiano TD, Hartzell S, Bin S, Cravedi P, Levitsky J. Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis. J Autoimmun 2021;119:102629. [PMID: 33721837 DOI: 10.1016/j.jaut.2021.102629] [Reference Citation Analysis]
45 Czaja AJ. Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease. World J Gastroenterol 2021; 27(25): 3705-3733 [PMID: 34321839 DOI: 10.3748/wjg.v27.i25.3705] [Reference Citation Analysis]
46 Chen C, Ke R, Yang F, Cai Q, Liu J, Huang X, Chen J, Xu F, Jiang Y. Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis. Medicine (Baltimore) 2020;99:e20205. [PMID: 32443344 DOI: 10.1097/MD.0000000000020205] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Li X, Xu H, Gao P. Red Blood Cell Distribution Width-to-Platelet Ratio and Other Laboratory Indices Associated with Severity of Histological Hepatic Fibrosis in Patients with Autoimmune Hepatitis: A Retrospective Study at a Single Center. Med Sci Monit 2020;26:e927946. [PMID: 33180750 DOI: 10.12659/MSM.927946] [Reference Citation Analysis]
48 Kapila N, Ma Q, King LY. It Ain't Over Till It's Over. Clin Liver Dis (Hoboken) 2020;16:33-7. [PMID: 32922746 DOI: 10.1002/cld.961] [Reference Citation Analysis]
49 Clermont-Dejean NM, Schwenger KJP, Salazar E, Colombo FF, Lu Z, Lou W, Gramlich L, Whittaker S, Armstrong D, Jurewitsch B, Raman M, Duerksen DR, McHattie JD, Murthy S, Allard JP. Home parenteral nutrition patients on mixed oil lipid emulsion have a higher rate of hospitalizations compare to those on soybean oil- a prospective 2-year cohort study. Clin Nutr 2021;40:4616-23. [PMID: 34229267 DOI: 10.1016/j.clnu.2021.06.012] [Reference Citation Analysis]
50 Sasamori Y, Tanaka A, Ayabe T. Liver disease in pregnancy. Hepatol Res 2020;50:1015-23. [PMID: 32583511 DOI: 10.1111/hepr.13540] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
51 Dorsey YC, Oloruntoba O, Pendse AA, King LY. More Than Meets the Eye? Clin Liver Dis (Hoboken) 2021;18:173-8. [PMID: 34745573 DOI: 10.1002/cld.1107] [Reference Citation Analysis]
52 Abbas Z, Asim M, Saeed A, Siddiqui B, Abbas M. The Spectrum of Autoimmune Liver Disorders, Clinical Presentation, and Autoantibodies in Patients From a Tertiary Care Center in Pakistan. Cureus 2021;13:e19789. [PMID: 34820249 DOI: 10.7759/cureus.19789] [Reference Citation Analysis]
53 Rela M, Jothimani D, Vij M, Rajakumar A, Rammohan A. Auto-immune hepatitis following COVID vaccination. J Autoimmun 2021;123:102688. [PMID: 34225251 DOI: 10.1016/j.jaut.2021.102688] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Ikura A, Chu PS, Nakamoto N, Ojiro K, Taniki N, Yoshida A, Shinoda M, Morikawa R, Yamataka K, Noguchi F, Hoshi H, Usui S, Ebinuma H, Kitagawa Y, Saito H, Kanai T. CLIF-C Organ Failure Score and Liver Volume Predict Prognosis in Steroid-Treated Severe Acute Autoimmune Hepatitis. Hepatol Commun 2020;4:1019-33. [PMID: 32626834 DOI: 10.1002/hep4.1521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Remash D, Prince DS, McKenzie C, Strasser SI, Kao S, Liu K. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021; 27(32): 5376-5391 [PMID: 34539139 DOI: 10.3748/wjg.v27.i32.5376] [Reference Citation Analysis]
56 Castellanos Fernández MI, Cepeda Mullo ME, la Rosa Hernández D, Vega Sánchez H, González Fabian L, Gish RG, Torres González AL, Dorta Guridi Z. Autoimmune Hepatitis in Cuban Patients: A Retrospective Analysis of Clinical and Histological Profiles, Treatments, and Outcomes. Curr Ther Res Clin Exp 2020;93:100594. [PMID: 32922567 DOI: 10.1016/j.curtheres.2020.100594] [Reference Citation Analysis]
57 Arndtz K, Shumbayawonda E, Hodson J, Eddowes PJ, Dennis A, Thomaides-Brears H, Mouchti S, Kelly MD, Banerjee R, Neubauer S, Hirschfield GM. Multiparametric Magnetic Resonance Imaging, Autoimmune Hepatitis, and Prediction of Disease Activity. Hepatol Commun 2021;5:1009-20. [PMID: 34141986 DOI: 10.1002/hep4.1687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmmune hepatitis. Cell Mol Immunol 2021. [PMID: 34580437 DOI: 10.1038/s41423-021-00768-8] [Reference Citation Analysis]
59 Liberal R, Macedo G. Acute severe autoimmune hepatitis - timing for steroids and role of other immunosuppressive agents. J Hepatol 2021;75:494-5. [PMID: 33933562 DOI: 10.1016/j.jhep.2021.03.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Czaja AJ. Review article: opportunities to improve and expand thiopurine therapy for autoimmune hepatitis. Aliment Pharmacol Ther 2020;51:1286-304. [PMID: 32363674 DOI: 10.1111/apt.15743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
61 Myneedu K, Chavez LO, Sussman NL, Michael M, Padilla A, Zuckerman MJ. Autoimmune Hepatitis in a Patient With Common Variable Immunodeficiency. ACG Case Rep J 2021;8:e00547. [PMID: 34549051 DOI: 10.14309/crj.0000000000000547] [Reference Citation Analysis]
62 Wang CW, Grab J, Tana MM, Irani RA, Sarkar M. Outcomes of Pregnancy in Autoimmune Hepatitis: A Population-Based Study. Hepatology 2021. [PMID: 34455632 DOI: 10.1002/hep.32132] [Reference Citation Analysis]
63 Shen Y, Xue M, Yang L. Letter to the editor: Both simplified and revised IAIHG scores should be considered in diagnosing acute autoimmune hepatitis. Liver Int 2021;41:1973-5. [PMID: 33988911 DOI: 10.1111/liv.14946] [Reference Citation Analysis]
64 Zhao EJ, Cheng CV, Mattman A, Chen LYC. Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management. Lancet Haematol 2021;8:e365-75. [PMID: 33894171 DOI: 10.1016/S2352-3026(21)00056-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Dalekos GN, Gatselis NK, Koukoulis GK. Non-alcoholic steatohepatitis or autoimmune hepatitis? Sometimes a closer look under the surface is needed. BMJ Case Rep 2020;13:e238400. [PMID: 33370951 DOI: 10.1136/bcr-2020-238400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study. Hepatology 2021;73:2099-109. [PMID: 33713486 DOI: 10.1002/hep.31797] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
67 Amir M, Parekh SM. Classic Autoimmune Liver Disorders and Celiac Hepatitis. Clin Liver Dis (Hoboken) 2021;17:347-52. [PMID: 34136140 DOI: 10.1002/cld.1056] [Reference Citation Analysis]
68 Beer A, Dienes HP. Autoimmune hepatitis-is histology conclusive? Ann Transl Med 2021;9:733. [PMID: 33987431 DOI: 10.21037/atm-20-5084] [Reference Citation Analysis]
69 Zachou K, Lygoura V, Arvaniti P, Giannoulis G, Gatselis NK, Koukoulis GK, Dalekos GN. FibroMeter scores for the assessment of liver fibrosis in patients with autoimmune liver diseases. Ann Hepatol 2021;22:100285. [PMID: 33157268 DOI: 10.1016/j.aohep.2020.10.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Fujiwara K, Yasui S, Kondo T, Yokosuka O, Kato N. Role of Autoimmunity in Patients Transplanted for Acute Liver Failure of Unknown Origin: A Clinical and Graft Biopsy Analysis. Liver Transpl 2021;27:309-10. [PMID: 33047498 DOI: 10.1002/lt.25917] [Reference Citation Analysis]
71 Muratori P, Granito A, Lenzi M, Muratori L. Limitation of the simplified scoring system for the diagnosis of autoimmune Hepatitis with acute onset. Liver Int 2021;41:529-34. [PMID: 33389800 DOI: 10.1111/liv.14778] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Zachou K, Arvaniti P, Lyberopoulou A, Dalekos GN. Impact of genetic and environmental factors on autoimmune hepatitis. J Transl Autoimmun 2021;4:100125. [PMID: 34622188 DOI: 10.1016/j.jtauto.2021.100125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Alswat K, Soliman E, Salih I, Bashmail A, Letierce A, Benmousa A, Alghamdi S, Bzeizi KI, Alqahtani SA, Shawkat M, Broering DC, Al-Hamoudi WK. Long Term Outcomes of Liver Transplantation For Patients With Autoimmune Hepatitis. Transplant Proc 2021;53:2339-45. [PMID: 34474912 DOI: 10.1016/j.transproceed.2021.07.040] [Reference Citation Analysis]
74 Sharma S, Agarwal S, Kaushal K, Anand A, Gunjan D, Yadav R, Saraya A. Presence and type of decompensation affects outcomes in autoimmune hepatitis upon treatment with corticosteroids. JGH Open 2021;5:81-90. [PMID: 33490617 DOI: 10.1002/jgh3.12451] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Huang C, Shen Y, Shen M, Fan X, Men R, Ye T, Yang L. Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis. Front Pharmacol 2021;12:726128. [PMID: 34531750 DOI: 10.3389/fphar.2021.726128] [Reference Citation Analysis]
76 Rezvani M. 50 Years Ago in TheJournal ofPediatrics: When "Chronic Active Hepatitis" Became Autoimmune Hepatitis. J Pediatr 2021;234:204. [PMID: 34172160 DOI: 10.1016/j.jpeds.2021.03.061] [Reference Citation Analysis]
77 Czaja AJ. Review article: targeting the B cell activation system in autoimmune hepatitis. Aliment Pharmacol Ther 2021;54:902-22. [PMID: 34506662 DOI: 10.1111/apt.16574] [Reference Citation Analysis]
78 Lohse AW, Sebode M, Jørgensen MH, Ytting H, Karlsen TH, Kelly D, Manns MP, Vesterhus M. Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group. Journal of Hepatology 2020;73:1496-506. [DOI: 10.1016/j.jhep.2020.07.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
79 Tesfaye BT, Feyissa TM, Workneh AB, Gudina EK, Yizengaw MA. Chronic Liver Disease in Ethiopia with a Particular Focus on the Etiological Spectrums: A Systematic Review and Meta-Analysis of Observational Studies. Can J Gastroenterol Hepatol 2021;2021:8740157. [PMID: 34858892 DOI: 10.1155/2021/8740157] [Reference Citation Analysis]
80 Oikonomou KG, Papamichalis P, Zafeiridis T, Xanthoudaki M, Papapostolou E, Valsamaki A, Bouliaris K, Papamichalis M, Karvouniaris M, Vlachostergios PJ, Skoura AL, Komnos A. Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions. World J Clin Cases 2021; 9(19): 4918-4938 [PMID: 34307544 DOI: 10.12998/wjcc.v9.i19.4918] [Reference Citation Analysis]
81 Gaber Y, AbdAllah M, Salama A, Sayed M, Abdel Alem S, Nafady S. Metabolic-associated fatty liver disease and autoimmune hepatitis: an overlooked interaction. Expert Rev Gastroenterol Hepatol 2021;:1-9. [PMID: 34263707 DOI: 10.1080/17474124.2021.1952867] [Reference Citation Analysis]
82 Chung Y, Rahim MN, Graham JJ, Zen Y, Heneghan MA. An update on the pharmacological management of autoimmune hepatitis. Expert Opin Pharmacother 2021;22:1475-88. [PMID: 33624559 DOI: 10.1080/14656566.2021.1895747] [Reference Citation Analysis]
83 Green EW, Kahl L, Jou JH. Systemic Sclerosis and the Liver. Clin Liver Dis (Hoboken) 2021;18:76-80. [PMID: 34584672 DOI: 10.1002/cld.1074] [Reference Citation Analysis]
84 Tan YW, Wang JM, Chen L. Is simultaneous presence of IgG4-positive plasma cells and giant-cell hepatitis a coincidence in autoimmune hepatitis? A case report. World J Clin Cases 2021; 9(25): 7527-7534 [PMID: 34616822 DOI: 10.12998/wjcc.v9.i25.7527] [Reference Citation Analysis]
85 Sharma R, Verna EC, Söderling J, Roelstraete B, Hagström H, Ludvigsson JF. Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31395-1. [PMID: 33065308 DOI: 10.1016/j.cgh.2020.10.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Islek A, Keskin H. Seronegative autoimmune hepatitis in children: a single-center experience. Acta Gastroenterol Belg 2021;84:305-10. [PMID: 34217180 DOI: 10.51821/84.2.305] [Reference Citation Analysis]
87 Rigopoulou EI, Dalekos GN. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers (Basel) 2021;13:1023. [PMID: 33804480 DOI: 10.3390/cancers13051023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
88 Zhu M, Hua T, Ouyang T, Qian H, Yu B. Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice. Stem Cells Int 2021;2021:6546780. [PMID: 34434239 DOI: 10.1155/2021/6546780] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Sharma S, Agarwal S, Gopi S, Anand A, Mohta S, Gunjan D, Yadav R, Saraya A. Determinants of Outcomes in Autoimmune Hepatitis Presenting as Acute on Chronic Liver Failure Without Extrahepatic Organ Dysfunction upon Treatment With Steroids. J Clin Exp Hepatol 2021;11:171-80. [PMID: 33746441 DOI: 10.1016/j.jceh.2020.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Li Y, Yan L, Wang R, Wang Q, You Z, Li B, Zhang J, Huang B, Chen Y, Li Y, Lian M, Tang R, Qiu D, Gershwin ME, Xiao X, Miao Q, Ma X. Serum Immunoglobulin G Levels Predict Biochemical and Histological Remission of Autoimmune Hepatitis Type 1: A Single-Center Experience and Literature Review. Clin Rev Allergy Immunol 2021. [PMID: 33512642 DOI: 10.1007/s12016-021-08833-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 McKiernan PJ. Multiparametric Magnetic Resonance Imaging to Monitor Pediatric Liver Disease: Looks Interesting but More Work to Do. J Pediatr Gastroenterol Nutr 2021;72:3-4. [PMID: 32960826 DOI: 10.1097/MPG.0000000000002949] [Reference Citation Analysis]
92 Dokmak A, Trivedi HD, Bonder A, Wolf J. Pregnancy in Chronic Liver Disease: Before and After Transplantation. Ann Hepatol 2021;:100557. [PMID: 34656772 DOI: 10.1016/j.aohep.2021.100557] [Reference Citation Analysis]
93 Janowski K, Shumbayawonda E, Dennis A, Kelly M, Bachtiar V, DeBrota D, Langford C, Thomaides-Brears H, Pronicki M, Grajkowska W, Wozniak M, Pawliszak P, Chełstowska S, Jurkiewicz E, Banerjee R, Socha P. Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis. J Pediatr Gastroenterol Nutr 2021;72:108-14. [PMID: 32925554 DOI: 10.1097/MPG.0000000000002930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
94 Zhang H, Liu M, Liu X, Zhong W, Li Y, Ran Y, Guo L, Chen X, Zhao J, Wang B, Zhou L. Bifidobacterium animalis ssp. Lactis 420 Mitigates Autoimmune Hepatitis Through Regulating Intestinal Barrier and Liver Immune Cells. Front Immunol. 2020;11:569104. [PMID: 33123141 DOI: 10.3389/fimmu.2020.569104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
95 Yodoshi T, Orkin S, Arce-Clachar AC, Bramlage K, Xanthakos SA, Mouzaki M, Valentino PL. Significance of autoantibody seropositivity in children with obesity and non-alcoholic fatty liver disease. Pediatr Obes 2021;16:e12696. [PMID: 32638543 DOI: 10.1111/ijpo.12696] [Reference Citation Analysis]
96 Gatselis NK, Azariadis K, Lyberopoulou A, Dalekos GN. Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis. J Transl Autoimmun 2021;4:100126. [PMID: 34632357 DOI: 10.1016/j.jtauto.2021.100126] [Reference Citation Analysis]
97 Zhang HP, Liu YM, Li Z, Ma YX, Li LJ, Zhao DT, Lou JL, Gao ZH, Yan HP. Clinical characteristics and HLA genotypes in Chinese patients with anti-SLA/LP-positive autoimmune hepatitis. Ann Transl Med 2021;9:153. [PMID: 33569455 DOI: 10.21037/atm-20-8036] [Reference Citation Analysis]
98 Liberal R, de Boer YS, Heneghan MA. Established and novel therapeutic options for autoimmune hepatitis. The Lancet Gastroenterology & Hepatology 2021;6:315-26. [DOI: 10.1016/s2468-1253(20)30328-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Fedrizzi RS, Coral GP, Mattos AA, Mattos ÂZ, Tovo CV. EVALUATION OF PATIENTS WITH AUTOIMMUNE HEPATITIS IN A SPECIALIZED OUTPATIENT CLINIC IN SOUTHERN BRAZIL. Arq Gastroenterol 2020;57:361-5. [PMID: 33237214 DOI: 10.1590/S0004-2803.202000000-69] [Reference Citation Analysis]
100 Noguchi F, Chu PS, Yoshida A, Taniki N, Morikawa R, Hasegawa Y, Yamataka K, Hoshi H, Kasuga R, Tabuchi T, Ebinuma H, Shinoda M, Obara H, Kitagawa Y, Kanai T, Nakamoto N. Early Dynamics of MELD Scores Predict Corticosteroid Responsiveness to Severe Acute-Onset Autoimmune Hepatitis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00609-1. [PMID: 34102339 DOI: 10.1016/j.cgh.2021.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Tan CK, Wong YJ, Wang LM, Ang TL, Kumar R. Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association? J Hepatol 2021:S0168-8278(21)00424-4. [PMID: 34153398 DOI: 10.1016/j.jhep.2021.06.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
102 Takeuchi Y, Noritake H, Matsumoto M, Umemura M, Yamashita M, Kitsugi K, Takatori S, Ohta K, Ito J, Shimoyama S, Kaysuya A, Maruyama C, Fukuchi K, Dohtan S, Sakata H, Kawata K. Azathioprine-induced severe myelosuppression accompanied by massive hair loss and painful oral ulcer in an autoimmune hepatitis patient with NUDT15 minor variant: A case report. Clin Case Rep 2021;9:e04696. [PMID: 34466252 DOI: 10.1002/ccr3.4696] [Reference Citation Analysis]
103 Rigopoulou EI, Gatselis N, Arvaniti P, Koukoulis GK, Dalekos GN. Alcoholic liver disease and autoimmune hepatitis: Sometimes a closer look under the surface is needed. Eur J Intern Med 2021;85:86-91. [PMID: 33451888 DOI: 10.1016/j.ejim.2020.12.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
104 Derben FC, Engel B, Zachou K, Hartl J, Hartleben B, Bantel H, Schramm C, Dalekos GN, Manns MP, Jaeckel E, Taubert R. CK-18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remission. Liver Int 2021;41:123-7. [PMID: 33043565 DOI: 10.1111/liv.14699] [Reference Citation Analysis]
105 Yang H, Sung PS, Jung ES, Cho S, Bae SH, Kim DW. Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option. Front Oncol 2020;10:1160. [PMID: 32754445 DOI: 10.3389/fonc.2020.01160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Olivas I, Cobreros M, Londoño MC, Díaz-González Á. Budesonide In The First Line Treatment Of Patients With Autoimmune Hepatitis. Gastroenterol Hepatol 2021:S0210-5705(21)00319-8. [PMID: 34923033 DOI: 10.1016/j.gastrohep.2021.11.012] [Reference Citation Analysis]
107 Fujita K, Oura K, Tadokoro T, Nakahara M, Tani J, Morishita A, Kobara H, Tsutsui K, Himoto T, Masaki T. Prognosis of probable autoimmune hepatitis patients: a single-center study in Japan. Intern Emerg Med 2021. [PMID: 33783693 DOI: 10.1007/s11739-021-02720-0] [Reference Citation Analysis]
108 Ducazu O, Degroote H, Geerts A, Hoorens A, Schouten J, Van Vlierberghe H, Verhelst X. Diagnostic and prognostic scoring systems for autoimmune hepatitis: a review. Acta Gastroenterol Belg 2021;84:487-95. [PMID: 34599574 DOI: 10.51821/84.3.014] [Reference Citation Analysis]
109 Llovet LP, Gratacós-Ginès J, Téllez L, Gómez-Outomuro A, Navascués CA, Riveiro-Barciela M, Vinuesa R, Gómez-Camarero J, García-Retortillo M, Díaz-Fontenla F, Salcedo M, García-Eliz M, Horta D, Guerrero M, Rodríguez-Perálvarez M, Fernández-Rodriguez C, Albillos A, G-Abraldes J, Parés A, Londoño MC. Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis. Hepatol Commun 2022. [PMID: 34989164 DOI: 10.1002/hep4.1889] [Reference Citation Analysis]
110 Biolato M, Bianco A, Lucchini M, Gasbarrini A, Mirabella M, Grieco A. The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review. CNS Drugs 2021;35:861-80. [PMID: 34319570 DOI: 10.1007/s40263-021-00842-9] [Reference Citation Analysis]
111 Zaky S, Alboraie M, El Badry M, Metwally MA, Abdelaziz A, Fouad Y, Abd-Elsalam S, Mahmoud A, Shiha G, Baki AA, El Kassas M, Esmat G. Management of liver disease patients in different clinical situations during COVID-19 pandemic. Egypt Liver J 2021;11:21. [PMID: 34777868 DOI: 10.1186/s43066-021-00091-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
112 Behairy BE, El-Said HH, Konswa HA, El-Deen AEN, Adawy NM, Sira AM. Predictors of azathioprine toxicity in children with autoimmune hepatitis. Clin Exp Hepatol 2021;7:47-54. [PMID: 34027115 DOI: 10.5114/ceh.2021.104634] [Reference Citation Analysis]
113 Komori A. Recent updates on the management of autoimmune hepatitis. Clin Mol Hepatol 2021;27:58-69. [PMID: 33291862 DOI: 10.3350/cmh.2020.0189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
114 Ziogas DC, Gkoufa A, Cholongitas E, Diamantopoulos P, Anastasopoulou A, Ascierto PA, Gogas H. When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report. J Immunother Cancer 2020;8:e001322. [PMID: 33144335 DOI: 10.1136/jitc-2020-001322] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
115 Vierling JM, Kerkar N, Czaja AJ, Mack CL, Adams D, Assis DN, Manns MP, Mayo MJ, Nayfeh T, Majzoub AMM, Alzuabi MA, Ding J, Haffar S, Murad MH, Alsawas M. Immunosuppressive Treatment Regimens in Autoimmune Hepatitis: Systematic Reviews and Meta‐Analyses Supporting American Association for the Study of Liver Diseases Guidelines. Hepatology 2020;72:753-69. [DOI: 10.1002/hep.31407] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
116 Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune Hepatitis: Serum Autoantibodies in Clinical Practice. Clin Rev Allergy Immunol 2021. [PMID: 34491531 DOI: 10.1007/s12016-021-08888-9] [Reference Citation Analysis]
117 Yang L, Ling W, He D, Lu C, Ma L, Tang L, Luo Y, Chen S. Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases. Quant Imaging Med Surg 2021;11:1532-42. [PMID: 33816189 DOI: 10.21037/qims-20-521] [Reference Citation Analysis]
118 Yan J, He YS, Song Y, Chen XY, Liu HB, Rao CY. False positive anti-hepatitis A virus immunoglobulin M in autoimmune hepatitis/primary biliary cholangitis overlap syndrome: A case report. World J Clin Cases 2021; 9(22): 6464-6468 [PMID: 34435013 DOI: 10.12998/wjcc.v9.i22.6464] [Reference Citation Analysis]